Lactulose ingestion increases faecal bifidobacterial counts: A randomised double-blind study in healthy humans

European Journal of Clinical Nutrition

Volumn 58, Issue 3, 2004, Pages 462-466

  Bouhnik, Yoram ^a   Attar, A ^a   Joly, F A ^a   Riottot, M ^b   Dyard, F ^c   Flourie B ^d  

^a HÔPITAL LARIBOISIÈRE   (France)

^b Lab de Physiologie de la Nutrition   (France)

^c Laboratoires Solvay Pharma   (France)

^d CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Bifidobacterium; Human; Intestinal microflora; Lactulose; Prebiotic; Randomised control trial

Indexed keywords

BILE ACID; LACTULOSE; PREBIOTIC AGENT; STEROL; SUCROSE;

ABDOMINAL PAIN; ADULT; ANAEROBIC BACTERIUM; ARTICLE; BACTERIAL COUNT; BIFIDOBACTERIUM; BLOATEDNESS; BORBORYGMI; CLINICAL TRIAL; COLON CARCINOGENESIS; COLONY FORMING UNIT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG TOLERABILITY; FECES ANALYSIS; FECES CULTURE; FEMALE; FLATULENCE; GASTROINTESTINAL SYMPTOM; HEALTH PROMOTION; HUMAN; HUMAN EXPERIMENT; LACTOBACILLUS; MALE; MEDICAL RECORD; METABOLIC PARAMETERS; NORMAL HUMAN; PH; RANDOMIZED CONTROLLED TRIAL; VOLUNTEER;

ADULT; BIFIDOBACTERIUM; BILE ACIDS AND SALTS; COLONIC NEOPLASMS; COLONY COUNT, MICROBIAL; DOUBLE-BLIND METHOD; FECES; FEMALE; FLATULENCE; HUMANS; HYDROGEN-ION CONCENTRATION; LACTOBACILLUS; LACTULOSE; MALE; PLACEBOS; STEROLS;

BIFIDOBACTERIUM; LACTOBACILLUS;

EID: 1842580496     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1601829     Document Type: Article

References (18)

1. Andrieux C, Gadelle D, Leprince C & Sacquet E (1989): Effects of some poorly digestible carbohydrates on bile acid bacterial transformations in the rat. Br. J. Nutr. 62, 103-119.
2. Ballongue J, Schumann C & Quignon P (1997): Effects of lactulose and lactitol on colonic microflora and enzymatic activity. Scand. J. Gastroenterol. Suppl. 222, 41-44.
3. Beerens H (1991): Detection of bifidobacteria by using propionic acid as a selective agent. Appl. Environ. Microbiol. 57, 2418-2419.
4. Berge Henegouwen GP, van der Werf SD & Ruben AT (1987): Effect of long term lactulose ingestion on secondary bile salt metabolism in man: Potential protective effect of lactulose in colonic carcinogenesis. Gut 28, 675-680.
5. Bouhnik Y, Pochart P, Marteau P, Arlet G, Goderel I & Rambaud JC (1992): Fecal recovery in humans of viable Bifidobacterium sp ingested in fermented milk. Gastroenterology 102, 875-878.
6. Buddington RK, Williams CH, Chen SC & Witherly SA (1996): Dietary supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects. Am. J. Clin. Nutr. 63, 709-716.
7. Challa A, Rao DR, Chawan CB & Shackelford L (1997): Bifidobacterium longum and lactulose suppress azoxymethane-induced colonic aberrant crypt foci in rats. Carcinogenesis 18, 517-521.
8. Gibson GR, Roberfroid MB (1995): Dietary modulation of the human colonic rnicrobiota: Introducing the concept of prebiotics. J. Nutr. 125, 1401-1412.
9. Hennigan TW, Sian M, Matthews J & Allen-Mersh TG (1995): Protective role of lactulose in intestinal carcinogenesis. Surg. Oncol. 4, 31-34.
10. Hoffmann K, Bircher J (1969): Changes in the bacterial population of the intestine following lactulose administration. Schweiz. Med. Wochenschr. 99, 608-609.
11. Nagengast FM, Hectors MP, Buys WA & van Tongeren JH (1988): Inhibition of secondary bile acid formation in the large intestine by lactulose in healthy subjects of two different age groups. Eur. J. Clin. Invest. 18, 56-61.
12. Nair PP (1988): Role of bile acids and neutral sterols in carcinogenesis. Am. J. Clin. Nutr. 48, 768-774.
13. Owen RW (1997): Faecal steroids and colorectal carcinogenesis. Scand. J. Gastroenterol. Suppl. 222, 76-82.
14. Riggio O, Varriale M, Testore GP, Di Rosa R, Di Rosa E, Merli M, Romiti A, Candiani C & Capocaccia L (1990): Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients. J. Clin. Gastroenterol. 12, 433-436.
15. Salminen S, Salminen E (1997): Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection. Scand. J. Gastroenterol. Suppl. 222, 45-48.
16. Singh J, Rivenson A, Tomita M, Shimamura S, Ishibashi N & Reddy BS (1997): Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 18, 833-841.
17. Terada A, Hara H, Kataoka M & Mitsuoka T (1992): Effect of lactulose on composition and metabolic activity of the human fecal flora. Microb. Ecol. Health Dis. 5, 43-50.
18. Tuohy KM, Ziemer CJ, Klinder A, Knöbel Y, Pool-Zobel BL & Gibson GR (2002): A human volunteer study to determine the prebiotic effects of lactulose powder on human colonic microbiota. Microb. Ecol. Health Dis. 14, 165-173.